Needham & Company Maintains a 'Buy' on Hologic (HOLX); Qtr In-line; Acquisition on Gen-Probe is Transformational
Go back to Needham & Company Maintains a 'Buy' on Hologic (HOLX); Qtr In-line; Acquisition on Gen-Probe is Transformational| Gen-Probe, Inc. (NASDAQ: GPRO) | Delayed: 0.60 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.60 | 52 Week High | $21.89 | |||
| Open | $0.60 | 52 Week Low | $8.62 | |||
| Day High | $0.60 | P/E | 0.58 | |||
| Day Low | $0.60 | EPS | $1.03 | |||
| Volume | 10,936 | |||||
| Hologic, Inc. (NASDAQ: HOLX) | Delayed: 76.01 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $76.01 | 52 Week High | $41.66 | |||
| Open | $76.01 | 52 Week Low | $31.84 | |||
| Day High | $76.01 | P/E | N/A | |||
| Day Low | $76.01 | EPS | $-4.40 | |||
| Volume | 338 | |||||
